Inovio Pharmaceuticals Inc. Stock Falls 6.9%, Underperforms Market

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. slid 6.9% to $1.21 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.

The stock's fall snapped an eight-day winning streak.

Inovio Pharmaceuticals Inc. closed 59.4% below its 52-week high of $2.98, which the company reached on September 9th.

The stock demonstrated a mixed performance when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Statera Biopharma Inc. fell 50.0% to $0.00, and Pfizer Inc. fell 1.59% to $27.79.

Trading volume totaled 4.1 million, compared to the 50-day average of 3.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 20, 2026 16:33 ET (20:33 GMT)